The financial pressure on American health systems has rarely been more acute. Providers are absorbing Medicaid cuts, margin compression and the compounding difficulty of competing for labor and reimbursement simultaneously. Larry Ellison, executive chairman and co-founder of Oracle, argues the framing is wrong.
“The goal is to provide the highest quality of care, but at a price that doesn’t ruin Western civilization,” Mr. Ellison said. “The great thing about higher-quality care, it’s actually cheaper.”
The argument is counterintuitive but internally consistent. Better clinical outcomes with fewer complications, fewer readmissions, and faster and more accurate diagnoses, reduce the total volume of care required. When a patient doesn’t need to return to the hospital, the system spends less. When a physician catches a drug interaction before it causes a crisis, the system spends less. The path to a sustainable cost structure runs through clinical improvement.
“Better outcomes mean you don’t have to go back into the hospital,” he said. Supporting health systems to provide high quality care and keep people out of the hospital is a core goal for Oracle Health.
Oracle’s platform connects wearables, smartwatches, blood pressure cuffs and prescription tracking to the health record, allowing clinicians to intervene before a patient deteriorates to the point of requiring readmission. The goal is to extend high-quality monitoring beyond the hospital walls to the full arc of a patient’s recovery — including the weeks at home after discharge. A post-chemotherapy check-in asking whether a patient is experiencing nausea or dizziness can catch a problem early enough to treat it with a medication refill rather than a hospital return. A missed prescription refill, flagged automatically, can prompt a reminder before it becomes a clinical event.
“People usually recover better at home,” Mr. Ellison said. “The problem is we don’t want to have to rush them back.”
The same philosophy applies to administrative waste. Prior authorization, the back-and-forth between providers and payers over treatment eligibility, consumes significant time and expense on both sides. AI that reads every applicable coverage rule and applies it to a specific patient’s clinical profile in real time changes the math.
“You’re much less likely to ask for prior authorization if you know you’re not going to get it, because the AI will tell you, ‘Well, your body mass index is too low,'” Mr. Ellison said. “It won’t be this back-and-forth, which is very frustrating and expensive for both the provider and the insurance company.”
Oracle has been working toward these goals through a range of clinical AI investments in 2026, including tools aimed at reducing administrative burden between providers and payers. Quality care and affordable care are not competing goals.
“There are a bunch of things we can do to improve the quality of care and simultaneously lower costs,” Mr. Ellison said.
